Overview

SR-BI and Antiviral Treatment Response in HCV

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The scavenger receptor type B class I (SR-BI) is a receptor for high-density lipoproteins (HDL) and one of entry factors for hepatitis C virus (HCV). The investigators aimed to examine the association of single nucleotide polymorphisms (SNPs) of the SCARB1 gene, which encodes SR-BI, with virologic responses to pegylated interferon-based treatment in Asian chronic hepatitis C (CHC) patients.
Details
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Treatments:
Antiviral Agents
Interferon-alpha
Peginterferon alfa-2a